New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
about
Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitroG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingRegulation of Bim in Health and DiseaseNew Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)Alphavbeta3-integrin antagonists inhibit thrombin-induced proliferation and focal adhesion formation in smooth muscle cellsRole of G protein-coupled receptors in inflammation.Thrombin-induced glucose transport via Src-p38 MAPK pathway in vascular smooth muscle cellsProtein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury.Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.Modifiers of symptomatic embolic risk in infective endocarditis.We can do it together: PAR1/PAR2 heterodimer signaling in VSMCsXimelagatran: the first oral direct thrombin inhibitor.Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.Clinical use of topical thrombin as a surgical hemostat.SCH 530348: a novel oral thrombin receptor antagonist.Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.Vascular PAR-1: activity and antagonism.Blood coagulation factor Xa as an emerging drug target.Thrombin use in surgery: an evidence-based review of its clinical use.Thrombin generation and atherosclerosis.Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.Platelet thrombin receptor antagonism with vorapaxar: pharmacology and clinical trial development.Emerging roles for vascular smooth muscle cell exosomes in calcification and coagulation.Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cells.Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase C delta mediates the activation.Inhibition of neointimal hyperplasia by a specific thrombin inhibitor.Thrombin promotes airway remodeling via protease-activated receptor-1 and transforming growth factor-β1 in ovalbumin-allergic rats.Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats.
P2860
Q24802453-FC0848AC-66C4-412A-9C6C-E04BCBD1B291Q26772221-81CCEB29-333F-4C68-8242-D5439EF0C1ACQ26781203-845A1697-E98C-4B38-ABEF-7BE4CE279158Q28081366-9B43FE3C-B3AE-4340-93CC-7A4D1929F8B2Q28510470-379161DD-FCFE-4A23-8E60-B007299F1A8EQ33858841-D9BDFF06-49C0-4BAE-8105-4ABD290557BDQ35049103-691F5E31-7259-459E-A994-2514A0A48CB8Q35062604-FD9E9DC2-AD62-47FB-8757-6DC726D30492Q35274033-25C0EEB0-9ADD-42F3-B833-29A2425C6DE6Q35460905-C9E25C87-A9F1-4C08-A836-FD4085A42943Q35599925-DA772E79-BCB4-44DD-A99B-4C203122FC0BQ35753482-0C045808-09AC-4A3F-90F4-37CFB3FB09CBQ36769644-88F67700-821E-4970-AFCF-A01B6CA54556Q37586947-DC6F215A-F37A-413D-A2D0-0F4CF26BE2EFQ37588688-3905B6DF-DBFE-41A0-802E-6CADEE4C5074Q37671483-35F17585-EA7C-4904-B505-86B211068F42Q37763262-1FEFC795-CF05-460C-8A4C-88F94EECDF1CQ37830708-E905D04A-33E8-4C0A-953A-E5AEE3052854Q37979181-CFA0D78A-6CDC-44FE-AC83-1A4E6F6C9615Q38163395-C1311359-BBA8-41A6-A960-A1A8AF6FD97CQ38402334-94463EAA-584E-40D6-8813-F91EFF87EFFFQ38592772-691A935B-2DAB-409E-9728-304199AB64B2Q40006523-66B48688-47E0-4B5F-92B1-848E7676B599Q42051446-E2505AEE-5248-430B-9250-A55D51C0EA96Q42320997-47436EEB-6E79-45CD-AF89-A0B11D462AA1Q44216648-A6716DFD-EAD5-41E2-BA99-AF9AA4B63D4AQ44942031-1C940655-D9B1-4A63-B444-7F7BDF63531EQ45803352-7DCD1175-130F-4327-8596-80C347328F18Q55069208-5D1B63B4-171C-4DB6-897B-FD3651F2C622
P2860
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@ast
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@en
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@nl
type
label
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@ast
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@en
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@nl
prefLabel
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@ast
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@en
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@nl
P2093
P356
P1433
P1476
New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.
@en
P2093
Madamanchi N
Patterson C
Stouffer GA
P304
P356
10.1161/HH1001.091447
P577
2001-05-01T00:00:00Z